Literature DB >> 18264666

A pheochromocytoma with normal clonidine-suppression test: how difficult the biochemical diagnosis?

Michelangelo Sartori, Alessandro Cosenzi, Elena Bernobich, Lorenzo A Calo, Giuseppe Bellini, Andrea Semplicini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18264666     DOI： 10.1007/s11739-008-0093-7

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  14 in total

1.  Biochemical diagnosis of pheochromocytoma: which test is best?

Authors:  Jacques W M Lenders; Karel Pacak; McClellan M Walther; W Marston Linehan; Massimo Mannelli; Peter Friberg; Harry R Keiser; David S Goldstein; Graeme Eisenhofer
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

2.  Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma.

Authors:  E L Bravo; R C Tarazi; F M Fouad; D G Vidt; R W Gifford
Journal:  N Engl J Med       Date:  1981-09-10       Impact factor: 91.245

3.  Glucagon and clonidine testing in the diagnosis of pheochromocytoma.

Authors:  E Grossman; D S Goldstein; A Hoffman; H R Keiser
Journal:  Hypertension       Date:  1991-06       Impact factor: 10.190

4.  Serum chromogranin-A assay in differential diagnosis of incidentally discovered adrenal masses.

Authors:  Luca Giovanella
Journal:  Anticancer Res       Date:  2005 May-Jun       Impact factor: 2.480

Review 5.  Catecholamine metabolism: a contemporary view with implications for physiology and medicine.

Authors:  Graeme Eisenhofer; Irwin J Kopin; David S Goldstein
Journal:  Pharmacol Rev       Date:  2004-09       Impact factor: 25.468

6.  Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results.

Authors:  Graeme Eisenhofer; David S Goldstein; McClellan M Walther; Peter Friberg; Jacques W M Lenders; Harry R Keiser; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

7.  Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass.

Authors:  Nicole Unger; Christian Pitt; Ingo Lopez Schmidt; Martin K Walz; Kurt W Schmid; Thomas Philipp; Klaus Mann; Stephan Petersenn
Journal:  Eur J Endocrinol       Date:  2006-03       Impact factor: 6.664

8.  Clonidine suppression test for pheochromocytoma: examples of misleading results.

Authors:  H C Taylor; D Mayes; A H Anton
Journal:  J Clin Endocrinol Metab       Date:  1986-07       Impact factor: 5.958

9.  Malignant phaeochromocytoma with high circulating DOPA, and clonidine-suppressible noradrenaline.

Authors:  D R McClean; L M Sinclair; T G Yandle; M G Nicholls
Journal:  Blood Press       Date:  1995-07       Impact factor: 2.835

10.  High plasma levels of human chromogranin A and adrenomedullin in patients with pheochromocytoma.

Authors:  Dario Cotesta; Chiara Caliumi; Piero Alò; Luigi Petramala; Maria Gabriella Reale; Raffaele Masciangelo; Alberto Signore; Rosario Cianci; Emilio D'Erasmo; Claudio Letizia
Journal:  Tumori       Date:  2005 Jan-Feb
View more
  1 in total

1.  The association between systolic blood pressure reduction during clonidine suppression testing and the decrease in plasma catecholamines and metanephrines.

Authors:  Tiran Golani; Boris Fishman; Yehonatan Sharabi; Yael Olswang-Kutz; Avshalom Leibowitz; Ehud Grossman; Gadi Shlomai
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-03       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.